198
Participants
Start Date
April 5, 2019
Primary Completion Date
November 30, 2022
Study Completion Date
November 30, 2022
Palbociclib
Palbociclib capsules orally once daily (QD) (at 100mg or 125mg depending on previous treatment dose) for 21 days every four weeks
Endocrine therapy
Endocrine therapy alone (letrozole or fulvestrant)
Hospital San Pedro de Alcantara, Cáceres
Centro Oncológico de Galicia, A Coruña
Instituto Europeo di Oncologia, Milan
Hospital Clinico San Carlos, Madrid
Hospital Universitario Sanchinarro, Madrid
Hospital Regional Universitario de Malaga, Málaga
Hospital Álvaro Cunqueiro, Vigo
Hospital Universitario Virgen de la Macarena, Seville
Instituto Valenciano de Oncología IVO, Valencia
Hospital General Universitari de Valencia, Valencia
Hospital de Basurto, Bilbao
Hospital Lozano Blesa, Zaragoza
Centre Paul Strauss, Strasbourg
CHD Vendee, La Roche-sur-Yon
Hôpital Jean Minjoz, Besançon
Polyclinique Bordeaux Nord Aquitaine, Bordeaux
Centre Georges François Leclerc, Dijon
Hopital Europeen Georges Pompidou, Paris
Hôpital Tenon AP-HP, Paris
University Hospital Dresden-GYN, Dresden
Kliniken Essen Mitte, Essen
Universitätsklinikum Essen Frauenklinik, Essen
AGAPLESION Markus Krankenhaus, Frankfurt
Technical University Munich, Munich
UKM Brustzentrum, Münster
Klinikum Ernst von Bergmann, Potsdam
Klinikum Mutterhaus der Borromäerinnen Trier, Trier
Ospedale Civili Brescia, Brescia
Oncologia Medica Ospedale di Prato, Prato
Policlinico Universitario Campus Bio-medico, Roma
Onkološki Inštitut Ljubljana, Ljubljana
Univerzitetni klinicni center Maribor Oddelek za onkologijo, Maribor
ICO Badalona, Badalona
Hospital Provincial de Castellón, Castelló
H. Vall Hebrón, Barcelona
Hospital del Mar, Barcelona
Institut Català d'Oncologia, Girona
Hospital Arnau de Vilanova, Lleida
Hospital La Paz, Madrid
Hospital Sant Joan, Reus
Hospital Universitario Virgen del Rocío, Seville
Hospital Arnau de Vilanova de Valencia, Valencia
Hospital Universitari i Politecnic La Fe, Valencia
Hospital Miguel Servet, Zaragoza
Darent Valley Hospital by Dartford and Gravesham NHS Trust, Dartford
Barts Cancer Institute, London
Consorci Sanitari de Terrassa, Terrassa
Institut Català d'Oncologia Bellvitge, Barcelona
Hospital Universitari Son Espases, Palma de Mallorca
Beatson West of Scotland Cancer Center, Glasgow
Kent Oncology Department, Maidstone
Abertawe Bro Morgannwg University Local Health Board, Singleton Hospital, Swansea
Royal Cornwall Hospital NHS Trust, Truro
Collaborators (1)
Pfizer
INDUSTRY
MedSIR
OTHER